Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-039705

Tobira Therapeutics, Inc. · TBRA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Christopher Peetz
Officer — Chief Financial Officer
Period of report
May 4, 2015
Accepted (ET)
May 6, 2015 · 9:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001311596

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Options (right to buy)F1,F2$4.81May 6, 2015A68,732A—Apr 27, 2024Common Stock68,73268,732D
Stock OptionsF1,F3$4.81May 6, 2015A31,091A—Apr 27, 2024Common Stock31,09199,823D

Explanation of responses